Gold vs US Dollar

Register for streaming realtime charts, analysis tools, and prices.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Corvus Pharmaceuticals Inc (CRVS)
Corvus Pharmaceuticals Inc (CRVS) Financials

CRVS Corvus Pharmaceuticals Inc

2.30

0.11 (5.02%)

18 May 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-30.489	-47.388	-44.073	-46.238	-7.087	-44.353	-46.492	-47.506
Return on Equity (%)	-71.534	-51.152	-48.1	-51.444	-8.369	-51.079	-53.898	-57.024
Return on Invested Capital (%)	-74.041	-52.362	-50.786	-54.141	-83.713	-89.454	-87.983	-101.416
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	3.773	4.032	3.763	2.544	2.543	2.087	1.205	0.789
Earnings Per Share	-1.033	-2.645	-1.601	-1.67	-0.211	-0.929	-0.887	-0.551
Cash Per Share	0.143	2.144	1.337	0.184	0.58	1.363	0.283	0.257
Working Capital Per Share	3.696	3.91	3.702	2.473	1.17	1.324	0.707	0.43
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	-1.033	-2.645	-1.601	-1.67	-0.211	-0.929	-0.887	-0.551
EBITDA Per Share	-1.033	-2.645	-1.601	-1.67	-0.211	-0.929	-0.887	-0.551
Free Cash Flow Per Share	-0.988	-2.673	-1.617	-1.695	-0.231	-0.939	-0.889	-0.554

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	22.886	10.172	16.449	7.76	3.732	7.358	4.061	4.07
Quick Ratio	22.694	10.041	16.308	7.627	3.643	7.218	3.989	3.952
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	20.92M	21.04M	29.32M	27.95M	28.37M	46.55M	46.55M	N/A

Key Stats and Ratios

Year End 31 December 2023	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	46.55M	46.55M	46.55M	46.55M	N/A	48.9M	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	6.947	N/A	N/A	N/A	4.288	N/A	N/A	N/A
Quick Ratio	6.794	N/A	N/A	N/A	4.209	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	112.79M
Price to Earnings Ratio	-4.17
Price to Sales Ratio	0
Price to Cash Ratio	8.94
Price to Book Ratio	2.92
Dividend Yield	-

Share Statistics

Shares Outstanding	49.04M
Average Volume (1 week)	313.91k
Average Volume (1 Month)	332.62k
52 Week Change	-8.37%
52 Week High	4.19
52 Week Low	1.05

More Ratios Coming Soon!

Corvus Pharmaceuticals

Vontobel Financial Produ...

Ethernity Networks

Ludwig Enterprises (PK)

Opiant Pharmaceuticals

Corporate Office Propert...

Neptune Wellness Solutions

L3 Technologies, Inc.

Helium One Global

Orcadian Energy

Novagold Resources

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions